Catalyst Wire Dossier Catalyst Wire Dossier

Arexvy

· GlaxoSmithKline
Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for Arexvy, covering 2024-05-21 to 2026-08-20. Get the full timeline:

Most recent: EMA Authorised: Arexvy — GlaxoSmithKline Biologicals S.A.

See pricing